Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Medical Developments International Limited (MDDVF)

Compare
0.5076
0.0000
(0.00%)
At close: March 26 at 4:00:00 PM EDT
Loading Chart for MDDVF
  • Previous Close 0.0000
  • Open 0.5500
  • Bid 0.3533 x --
  • Ask 0.4322 x --
  • Day's Range 0.3093 - 0.3093
  • 52 Week Range 0.2480 - 0.5500
  • Volume 2,500
  • Avg. Volume 3
  • Market Cap (intraday) 57.185M
  • Beta (5Y Monthly) 1.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2900
  • Earnings Date Feb 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 4, 2013
  • 1y Target Est --

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. The company was founded in 1972 and is headquartered in Scoresby, Australia.

medicaldev.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: MDDVF

View More

Performance Overview: MDDVF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

MDDVF
104.68%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

MDDVF
7.71%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

MDDVF
86.64%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

MDDVF
92.95%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: MDDVF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDDVF

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    36.69M

  • Enterprise Value

    27.00M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.17

  • Price/Book (mrq)

    1.65

  • Enterprise Value/Revenue

    1.30

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -78.16%

  • Return on Assets (ttm)

    -1.23%

  • Return on Equity (ttm)

    -45.40%

  • Revenue (ttm)

    38.05M

  • Net Income Avi to Common (ttm)

    -29.74M

  • Diluted EPS (ttm)

    -0.2900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.62M

  • Total Debt/Equity (mrq)

    3.87%

  • Levered Free Cash Flow (ttm)

    6.33M

Research Analysis: MDDVF

View More

Company Insights: MDDVF

Research Reports: MDDVF

View More

People Also Watch